RCT: Added Value of Coordinator for the Management of Hip Fracture Patients

Randomized Controlled Trial: Added Value of Coordinator for the Management of Hip Fracture Patients in a Network of Public Hospitals in Brussels.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01785381

Enrollment

128

Registered

2013-02-07

Start date

2012-12-31

Completion date

2014-12-31

Last updated

2013-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Keywords

Osteoporosis, hip fracture, fractures, Bone density

Brief summary

Introduction: Hip fracture due to osteoporosis is associated with an extremely high mortality morbidity and loss of quality of life. The risk of future fracture after a first hip fracture is increased. Several studies reported that patients who suffered from a fracture are not optimally treated and do not receive osteoporosis treatment after the first fracture episode. Aim: To evaluate whether a coordinator increases the optimal management of osteoporotic fracture patients and hip fracture patients.

Detailed description

Material and methods: Population: Identification in the IRIS public hospital network of all patients above 50 years who suffer from hip fracture. Exclusion of those due to high energy fractures and due to known cancer. First observational phase of treatment followed by randomized controlled trials of 2 years. Intervention (RCT): Added value of a coordinator. Measured outcomes : A. New fractures. B. A score of optimal management of osteoporosis. Definition of the score and management: 1. Realization of a bone density measurement. 2. Identification of secondary osteoporosis. 3. Identification of risk factors and calculation of the probability of a future fracture using FRAX score. 4. Attempt to correct risk factors of osteoporosis when possible. 5. Prevention of falls. 6. Prescription of calcium and vitamin D. 7. Prescription of a medical osteoporosis treatment. 8. Report to the general practitioner.

Interventions

OTHERAdded value of coordinator

Added value of coordinator

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

50 Years to No maximum

Healthy volunteers

Inclusion criteria

* Identification in the IRIS public hospital network of all patients above 50 years who suffer from hip fracture.

Exclusion criteria

* Exclusion of those due to high energy fractures and due to known cancer.

Design outcomes

Primary

Measure	Time frame	Description
A score of optimal management of osteoporosis.	3-6 months	Definition of the score and management: 1. Realization of a bone density measurement. 2. Identification of secondary osteoporosis. 3. Identification of risk factors and calculation of the probability of a future fracture using FRAX score. 4. Attempt to correct risk factors of osteoporosis when possible. 5. Prevention of falls. 6. Prescription of calcium and vitamin D. 7. Prescription of a medical osteoporosis treatment. 8. Report to the general practitioner.

Secondary

Measure	Time frame
New fractures.	2 years

Countries

Belgium

Contacts

Primary ContactKatty Renard, RN

katty_renard@stpierre-bru.be+32 2 535 48 56

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026